DEXAMETHASONE | A088254 | PHARMOBEDIENT CONSULTING
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lachman Consultant Services, Inc. FDA-2026-P-1306 · 5 docket documents Lachman Consultant Services, Inc. filed this petition requesting that the FDA determine whether the Reference Listed Drug Dexamethasone Elixir 0.5 mg/5 mL, approved under ANDA 088254, was voluntarily withdrawn from sale for safety or efficacy reasons. The petitioner believes the discontinuation was | 505(q) | 2026-02-05 | Granted | Lachman Consultant Services, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.